At 13.2% CAGR, Middle East & Africa Genetic Testing Services Market is Projected to be Worth US$ 236.91 Million by 2031 says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa genetic testing services market was valued at US$ 87.99 million in 2023 and is expected to reach US$ 236.91 million by 2031, registering a CAGR of 13.2% from 2023 to 2031. Rising prevalence of genetic disease and increasing awareness and acceptance of personalized medicines are among the critical factors attributed to drive the Middle East & Africa genetic testing services market.

The prevalence of genetic diseases is rising across the world and impacting the health of people at a severe level. Genetic diseases show many symptoms that are uncommon and are mostly non-curable. Most of the genetic diseases are rare and are developed due to the mutation in the genetic makeup of the people. According to The World Health Organization (WHO) 2021, 10 out of every 1,000 people are affected by single-gene diseases, signifying that 70 million and 80 million people worldwide are living with any one type of single-gene disease. As per the Global Genes, ~7,000 known rare diseases and disorders have been identified worldwide, and more are being discovered every year.

According to the University of Sheffield research, ~300 million people are living with genetic diseases around the world. In 2022, a report by MJH Life Sciences (US) estimated that 300,000 newborns worldwide are born with sickle cell disease every year, accounting for ∼5% of the global population.

In Middle East, a very large population is diagnosed with genetic diseases due to consanguineous marriage favored in many communities. Marriages between relatives are the major concern for the rising prevalence of genetic diseases. The burden of autosomal recessive disease variations is high in Saudi Arabia due to the highly consanguineous population. To control these conditions, countries in the Middle East are mandatorily conducting genetic evaluations for couples getting married so that the prevalence of these diseases can be managed and treated timely.

Thus, the rising prevalence of genetic diseases fuels the demand for genetic testing, which in turn drives genetic testing services market growth

On the flip side, affordability of genetic services hampers the growth of Middle East & Africa genetic testing services market.

Based on service type, the Middle East & Africa genetic testing services market is segmented into predictive testing, carrier testing, prenatal testing, new-born screening, diagnostic genetic testing, and others. The predictive testing segment held 31.5% market share in 2023, amassing US$ 27.74 million. It is projected to garner US$ 78.52 million by 2031 to register 13.9% CAGR during 2023–2031.

In terms of disease, the Middle East & Africa genetic testing services market is categorized into cancer, cardiovascular disease, metabolic disease, and other disease. The cancer segment held 51.3% share of Middle East & Africa Genetic Testing Services Market in 2023, amassing US$ 45.15 million. It is anticipated to garner US$ 131.59 million by 2031 to expand at 14.3% CAGR during 2023–2031.

In terms of service provider, the Middle East & Africa genetic testing services market is categorized into hospital-based laboratories, diagnostic laboratories, and other service provider. The hospital-based laboratories segment held 63.3% share of Middle East & Africa genetic testing services market in 2023, amassing US$ 55.70 million. It is projected to garner US$ 160.23 million by 2031 to expand at 14.1% CAGR from 2023 to 2031.

Based on country, the Middle East & Africa genetic testing services market is categorized into the Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 30.2% share of Middle East & Africa genetic testing services market in 2023. It was assessed at US$ 26.60 million in 2022 and is likely to hit US$ 78.56 million by 2031, registering a CAGR of 14.5% during 2023–2031.

Key players operating in the genetic testing services market are Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, 23andMe Holding Co, Ambry Genetics Corp, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Inc, Centogene NV, Ancestry Genomics Inc, Gene By Gene Ltd, SIVOTEC BioInformatics LLC, Progenesis, Fulgent Genetics, Inc, VERITAS INTERCONTINENTAL, GeneDx, LLC.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com